Jinling Pharmaceutical Company Limited

000919

CNE0000010W5

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 02/07/2024 am IST			5-day change	1st Jan Change
6.49 ^CNY	+1.25%		+4.51%	-17.53%

12/06	Hefei Jinling Tianyi Smart Elderly Care Services Co., Ltd. announced that it has received CNY 600 million in funding from Jinling Pharmaceutical Company Limited	CI
24/05	Jinling Pharmaceutical Company Limited Announces Final Dividend on A Shares for the Year 2023, Payable on 31 May 2024	CI

Jinling Pharmaceutical Company Limited(SZSE:000919) dropped from Shenzhen Stock Exchange Component A Share Index

January 03, 2016 at 10:30 am IST

Jinling Pharmaceutical Company Limited will be removed from Shenzhen Stock Exchange Component A Share Index.

Latest news about Jinling Pharmaceutical Company Limited

Hefei Jinling Tianyi Smart Elderly Care Services Co., Ltd. announced that it has received CNY 600 million in funding from Jinling Pharmaceutical Company Limited	12/06	CI
Jinling Pharmaceutical Company Limited Announces Final Dividend on A Shares for the Year 2023, Payable on 31 May 2024	25/05	CI
Jinling Pharmaceutical Company Limited Approves Cash Dividend for the Year 2023	22/05	CI
Jinling Pharmaceutical Company Limited Proposes Final Cash Dividend for the Year 2023	30/04	CI
Jinling Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04	CI
Hefei Jinling Tianyi Smart Elderly Care Services Co., Ltd. announced that it expects to receive CNY 600 million in funding from Jinling Pharmaceutical Company Limited	26/04	CI
Jinling Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	18/04	CI
Jinling Pharmaceutical Company Limited announced that it has received CNY 749.999998 million in funding from a group of investors	08/04	CI
Jinling Pharma in Talks to Buy Over 50% Stake in Local Hospital	05/01	MT
Jinling Pharmaceutical Company Limited agreed to acquire 43.6% stake in Nanjing Meishan Hospital Co., Ltd. from Nanjing New Industrial Investment Group Co.,Ltd. and Nanjing Zijin Investment Management Co., Ltd.	05/01	CI
Jinling Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	30/23/30	CI
Jinling Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	18/23/18	CI
Jinling Pharma Selling 750 Million Yuan Shares to Fund New Projects	24/23/24	MT
Jinling Pharmaceutical Company Limited Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 14 July 2023	08/23/08	CI
Jinling Pharmaceutical Company Limited Approves Management Appointments	30/23/30	CI
Jinling Pharmaceutical Company Limited Approves Cash Dividend for the Year 2022	25/23/25	CI
Jinling Pharmaceutical Vice Chairman Resigns	15/23/15	MT
Jinling Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	28/23/28	CI
Jinling Pharmaceutical Company Limited Proposes Final Cash Dividend for the Year 2022	24/23/24	CI
Jinling Pharmaceutical Company Limited announced that it expects to receive CNY 750 million in funding from Nanjing New Industrial Investment Group Co., Ltd and other investors	24/23/24	CI
Jinling Pharma Gets 155 Million Yuan Compensation for Office Demolition, Relocation	23/23/23	MT
Jinling Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2022	27/22/27	CI
Jinling Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22/22/22	CI
Jinling Pharmaceutical Company Limited Implements Final Profit Distribution for 2021, Payable on August 11, 2022	05/22/05	CI
Jinling Pharmaceutical Company Limited Approves Cash Dividend for the Year 2021	30/22/30	CI

Chart Jinling Pharmaceutical Company Limited

Duration

Period

Chart Jinling Pharmaceutical Company Limited

More charts

Jinling Pharmaceutical Company Limited is a China-based company principally engaged in the manufacture and sale of traditional Chinese medicines and chemical drugs. The Companyâs main products include Mailuoning injections, ferrous succinate tablets and Lentinan injection, among others. The Company is also involved in the provision of medical services and the sale of medical instrument. The Company distributes its products in domestic market, with North China as its main market.

Sector

Pharmaceuticals

Calendar

27/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
JINLING PHARMACEUTICAL COMPANY LIMITED	-17.53%	561M
ELI LILLY AND COMPANY	+55.83%	816B
NOVO NORDISK A/S	+39.32%	634B
JOHNSON & JOHNSON	-7.52%	351B
MERCK & CO., INC.	+16.49%	323B
ABBVIE INC.	+7.45%	293B
ASTRAZENECA PLC	+13.25%	238B
ROCHE HOLDING AG	+0.86%	222B
NOVARTIS AG	+13.41%	218B
AMGEN INC.	+8.12%	167B